FDA
approval
· 2024-11-21
FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved a supplemental application for Ketorolac Tromethamine from Teva Pharmaceuticals USA, Inc., under an ANDA to update the approved product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)